WAYNE, N.J., Dec. 18 Bayer HealthCare today announced acharitable gift of $85,000 to the Multiple Sclerosis Foundation (MSF) to fundprograms that provide aid and support for those living with multiple sclerosis(MS). The donation, made by the Bayer Foundation, is one of many each yearthat funds the programs of advocacy organizations that serve the needs ofpeople affected by conditions that Bayer HealthCare products treat.
The MSF offers a variety of support services to improve the quality oflife for people with MS by enhancing comfort, safety and self-sufficiency.The donation from the Bayer Foundation will help fund the following MSFprograms:
"Patient education and care are the cornerstones of our organization, andwe are grateful for Bayer HealthCare's generosity," said Alan Segaloff,Executive Director, Multiple Sclerosis Foundation. "This charitablecontribution will help us continue to motivate, educate and empowerindividuals with MS and their loved ones."
MS is a chronic, progressive disease of the central nervous system thatcauses irreparable nerve damage. There are at least 400,000 Americans with MS,and every week about 200 new people are diagnosed with the condition.
"We are proud to support and work with patient service groups, such as theMSF, which work tirelessly to improve the lives of people with MS," saidLudger Heeck, Ph.D., Vice President and General Manager, SpecializedTherapeutics, Bayer HealthCare Pharmaceuticals. "This donation reflects ourongoing commitment to supporting those who are affected by the condition."
The Bayer Foundation is an endowed 501(c)(3) entity and the primary sourcefor Bayer HealthCare's philanthropic giving throughout the United States. Itsupports programs that enhance the quality of life, provide unique andenriching opportunities that connect diverse groups and ensure preparednessfor tomorrow's leaders.
About Multiple Sclerosis
MS is a chronic, progressive disease of the central nervous system.Symptoms of MS vary from person to person and can be unpredictable. They mayinclude: fatigue or tiredness, visual dysfunction in one or both eyes,weakness in one or more extremities, numbness and tingling in the face, arms,legs and trunk of the body, spasticity (muscle stiffness), dizziness, slurredspeech and bladder dysfunction.
About the Multiple Sclerosis Foundation
The Multiple Sclerosis Foundation (MSF) is a publicly funded 501(c)(3)organization that was established in 1986. Headquartered in Fort Lauderdale,Florida, the MSF is a predominantly service-based organization that strives toensure the best quality of life for those coping with MS by providingcomprehensive support and educational programs. The MSF supports research intothe cause and cure of MS, as well as investigations of various medical andcomplementary treatment options.
About Bayer HealthCare Pharmaceuticals
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticalsunit of Bayer HealthCare LLC, a division of Bayer AG. One of the world'sleading, innovative companies in the healthcare and medical products industry,Bayer HealthCare combines the global activities of the Animal Health, ConsumerCare, Diabetes Care, and Pharmaceuticals divisions. In the U.S., BayerHealthCare Pharmaceuticals comprises the following business units: Women'sHealthcare, Diagnostic Imaging, Specialized Therapeutics,Hematology/Cardiology and Oncology. The company's aim is to discover andmanufacture products that will improve human health worldwide by diagnosing,preventing and treating diseases.
This news release contains forward-looking statements based on currentassumptions and forecasts made by Bayer Group management. Various known andunknown risks, uncertainties and other factors could lead to materialdifferences between the actual future results, financial situation,developm